An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Investigational Drug Gaining Popularity Online
Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are urged to message these accounts privately for source information, while also receiving promotional offers.
Active Trade on Social Networks
Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison photos, administration instructions and claims of rapid UK delivery. Vendors promote the substance there before redirecting customers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Experts Voice Worries
However, doctors and chemists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting products of unknown origin.
Several experts said the popularity for the experimental drug could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.
Several influencers attempt to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach pharmaceutical, marketing, and consumer laws, potentially leading to penalties, prosecution or prison.
Platform Reaction and Content Removal
According to TikTok, the platform has taken down problematic content and prohibited related hashtags and search suggestions. The organization said it was dedicated to maintaining the platform safe and investing in strengthening enforcement strategies.
Digital Trading Operations
Investigations also found groups with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, filled with photos of weight loss, glowing testimonials and detailed instructions for mixing or injecting at home.
Within minutes of entering one group, a vendor posted WhatsApp details, where the majority of purchases take place. The seller sent an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about body mass, medical conditions or past usage.
Product Details and Costs
Within these communities, posts display dark colored packages with Royal Mail stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at residence with purified liquid, or pre-filled injectors typically priced at £160 for 20mg. When asked how much time a injector should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for the messaging service stated it regularly monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering materials they can’t verify. Even if the research behind retatrutide is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.
Her staff has previously encountered patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to potentially serious health risks”.
